Nanomolar detection of lurasidone hydrochloride in pharmaceutical formulations (Serodopamoun®) and spiked urine using a PVC/imprinted polymer/MWCNTs layer deposited onto polyaniline-coated screen-printed electrodes
Menna M. El-Beshlawy, Ahmed Barhoum, Fatehy M. Abdel-Haleem · 2024
Read Nanomolar detection of lurasidone hydrochloride in pharmaceutical formulations (Serodopamoun®) and spiked urine using a PVC/imprinted polymer/MWCNTs layer deposited onto polyaniline-coated screen-printed electrodes by Menna M. El-Beshlawy, Ahmed Barhoum, Fatehy M. Abdel-Haleem (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11653105.txt.
Description
Menna El-Beshlawy, Ahmed Barhoum, and Fatehy Abdel-Haleem report a new sensor study from 2024. Their work seeks a fast, low-cost way to measure lurasidone, a drug used to treat schizophrenia and bipolar I disorder. The team built the test on small printed electrodes coated with thin plastic layers. One layer was molded to fit the drug itself, so the sensor would respond to that drug more than to other compounds.
Tests showed the sensor could find the drug at very low levels in lab samples. It gave a clear signal within two to three minutes and stayed selective for the target drug. The authors also tested urine samples spiked with a brand-name form of the drug. They argue the device could offer a cheaper option than standard lab methods for drug checks.
Catalog record
| CREATOR | Menna M. El-Beshlawy, Ahmed Barhoum, Fatehy M. Abdel-Haleem |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |